YEWB Stock Overview
Yew Bio-Pharm Group, Inc., through its subsidiaries, grows and sells yew trees in the People’s Republic of China and the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Yew Bio-Pharm Group, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0002 |
| 52 Week High | US$0.001 |
| 52 Week Low | US$0.0002 |
| Beta | 0 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -99.83% |
| 5 Year Change | -99.89% |
| Change since IPO | -99.98% |
Recent News & Updates
Recent updates
Shareholder Returns
| YEWB | US Food | US Market | |
|---|---|---|---|
| 7D | 0% | -5.0% | -3.5% |
| 1Y | n/a | -5.2% | 22.1% |
Return vs Industry: Insufficient data to determine how YEWB performed against the US Food industry.
Return vs Market: Insufficient data to determine how YEWB performed against the US Market.
Price Volatility
| YEWB volatility | |
|---|---|
| YEWB Average Weekly Movement | n/a |
| Food Industry Average Movement | 4.8% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 17.0% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: YEWB has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine YEWB's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | n/a | Guifang Qi | www.yewbiopharm.com |
Yew Bio-Pharm Group, Inc., through its subsidiaries, grows and sells yew trees in the People’s Republic of China and the United States. It offers traditional Chinese medicine (TCM) raw materials in the form of yew tree branches and leaves to manufacture TCM containing taxol. The company is also involved in processing and selling yew raw materials used in the manufacture of traditional Chinese medicine; growing and selling yew tree seedlings and mature trees, including potted miniature yew trees; manufacturing and selling furniture and handicrafts made of yew tree timber; selling agricultural products, such as yew candles, pine needle extracts, taxus cuspidate extracts, northeast yew extracts, and yew essential oil soaps; and selling wood ear mushroom.
Yew Bio-Pharm Group, Inc. Fundamentals Summary
| YEWB fundamental statistics | |
|---|---|
| Market cap | US$10.34k |
| Earnings (TTM) | US$402.84k |
| Revenue (TTM) | US$29.05m |
0.0x
P/E Ratio0.0x
P/S RatioIs YEWB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| YEWB income statement (TTM) | |
|---|---|
| Revenue | US$29.05m |
| Cost of Revenue | US$28.89m |
| Gross Profit | US$162.90k |
| Other Expenses | -US$239.95k |
| Earnings | US$402.84k |
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did YEWB perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/11/09 14:30 |
| End of Day Share Price | 2023/10/19 00:00 |
| Earnings | 2021/09/30 |
| Annual Earnings | 2020/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Yew Bio-Pharm Group, Inc. is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|